A rating of 100 puts Diffusion Pharmaceuticals Inc (DFFN) near the top of the Biotechnology industry according to InvestorsObserver. Diffusion Pharmaceuticals Inc's score of 100 means it scores higher than 100% of stocks in the industry. Diffusion Pharmaceuticals Inc also received an overall rating of 95, putting it above 95% of all stocks. Biotechnology is ranked 19 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Diffusion Pharmaceuticals Inc Stock Today?
Diffusion Pharmaceuticals Inc (DFFN) stock is trading at $1.33 as of 3:16 PM on Friday, Feb 19, a loss of -$0.12, or -7.99% from the previous closing price of $1.44. The stock has traded between $1.31 and $1.45 so far today. Volume today is 10,438,660 compared to average volume of 11,410,284.